Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia (BESTCILIA): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial

2020136 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: The Lancet Respiratory Medicine

Volume 8, Issue 5, pp. 493-505

Field-Weighted Citation Impact: 10.38